Is total neoadjuvant treatment beneficial for locally advanced rectal cancer? a meta-analysis of randomized controlled trials

被引:1
|
作者
Wu, Hai-Qiong [1 ,3 ]
Li, Jun [2 ]
Miao, Ji-Dong [1 ]
Li, Jia-Wei [1 ]
机构
[1] Zigong Fourth Peoples Hosp, Dept Oncol, Zigong 643000, Sichuan, Peoples R China
[2] Zigong Fourth Peoples Hosp, Dept Anesthesiol, Zigong 643000, Sichuan, Peoples R China
[3] Zigong Fourth Peoples Hosp, Dept Oncol, 19 Tanmulin Rd, Zigong 643000, Sichuan, Peoples R China
关键词
rectal cancer; neoadjuvant radiochemotherapy; surgery; meta-analysis; TOTAL MESORECTAL EXCISION; PREOPERATIVE CHEMORADIATION; ADJUVANT CHEMOTHERAPY; PHASE-II; CONCOMITANT CHEMORADIOTHERAPY; CONSOLIDATION CHEMOTHERAPY; PATHOLOGICAL RESPONSE; OPEN-LABEL; FOLLOW-UP; SURGERY;
D O I
10.1159/000534815
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Total neoadjuvant therapy (TNT) is a new strategy combining neoadjuvant therapy and chemotherapy to enhance tumor shrinkage and systemic control. Its effectiveness remains debated.Objectives: This study conducts a meta-analysis of randomized controlled trials (RCTs) to assess TNT's impact and provide high-quality evidence for rectal cancer treatment decisions.Method: We searched China National Knowledge Infrastructure, VIP Database, Wanfang Database, China biomedical literature database, PubMed database, Embase database, and The Cochrane Library for RCTs comparing TNT with neoadjuvant chemoradiotherapy (CRT) in locally advanced rectal cancer. The included trials were screened and assessed for quality based on inclusion and exclusion criteria, and meta-analysis was performed using RevMan 5.3 software.Results: A total of 11 RCTs reported in 14 articles, with 1624 cases in the TNT group and 1541 cases in the CRT group. The results of the meta-analysis showed that compared with the CRT group, the TNT group had a higher pathological complete response rate (RR=1.65, 95% CI [1.40, 1.94], P<0.00001), higher T0 downstaging rate (RR=1.51, 95% CI [1.29, 1.77], P<0.00001), higher 3-year overall survival (HR=0.81, 95% CI [0.67, 0.98], P=0.03), and higher 3-year disease-free survival (HR=0.82, 95% CI [0.70, 0.95], P=0.008). However, there was no statistically significant difference between the two groups in terms of R0 resection rate (RR=1.02, 95% CI [0.99, 1.05], P=0.14), sphincter preservation rate (RR=0.94, 95% CI [0.88, 1.01], P=0.12), anastomotic leakage rate (RR=1.42, 95% CI [0.85, 2.38], P=0.18), and grade 3 or higher adverse events (RR=1.21, 95% CI [0.95, 1.54], P=0.13).Conclusions: In the treatment of locally advanced rectal cancer, TNT offers greater survival benefits compared to neoadjuvant CRT and does not significantly increase the incidence of adverse events. However, further data and studies with long-term outcomes are still required.
引用
收藏
页码:399 / 413
页数:15
相关论文
共 50 条
  • [31] Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials
    Zhao, L.
    Liu, R.
    Zhang, Z.
    Li, T.
    Li, F.
    Liu, H.
    Li, G.
    COLORECTAL DISEASE, 2016, 18 (08) : 763 - 772
  • [32] Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer
    Conces, Madison L.
    Mahipal, Amit
    CURRENT ONCOLOGY, 2024, 31 (01) : 366 - 382
  • [33] Author response: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis
    Wu, Qingbin
    He, Yazhou
    Wang, Ziqiang
    BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [34] Total neoadjuvant therapy for locally advanced rectal cancer
    Cercek, Andrea
    Roxburgh, Campbell S. D.
    Strombom, Paul
    Smith, Jesse Joshua
    Temple, Larissa K. F.
    Nash, Garrett Michael
    Guillem, Jose G.
    Paty, Philip
    Garcia-Aguilar, Julio
    Yaeger, Rona D.
    Stadler, Zsofia Kinga
    Segal, Neil Howard
    Reidy, Diane Lauren
    Shia, Jinru
    Vakiani, Efsevia
    Wu, Abraham Jing-Ching
    Crane, Christopher H.
    Gollub, Marc Jeffrey
    Saltz, Leonard
    Weiser, Martin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [35] Neoadjuvant treatment in locally advanced rectal cancer
    Akgun, Zuleyha
    Kaytan Saglam, Esra
    MARMARA MEDICAL JOURNAL, 2015, 28 (04): : 16 - 20
  • [36] Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer: a meta-analysis of randomized controlled trials
    Boustead, Gregory
    Edwards, Steven J.
    BJU INTERNATIONAL, 2007, 99 (06) : 1383 - 1389
  • [37] Compare clinical efficacy and safety of neoadjuvant therapy and neoadjuvant chemoradiotherapy for locally advanced rectal cancer: Meta-analysis
    Wang, Ying
    Yang, Yan
    Liu, Qi-Qi
    Wang, Shao-Zhao
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (06):
  • [38] Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis
    Liu, Guo-Chen
    Yan, Jun-Ping
    He, Qing
    An, Xin
    Pan, Zhi-Zhong
    Ding, Pei-Rong
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [39] Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis
    Des Guetz, Gaetan
    Landre, Thierry
    Bollet, Marc A.
    Mathonnet, Muriel
    Quero, Laurent
    CANCERS, 2021, 13 (23)
  • [40] Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
    Chen, Min
    Chen, Liang-zhou
    Xu, Lin
    Zhang, Jin-song
    Song, Xue
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 741 - 758